# Safety and Efficacy of Apixaban in Severe Renal Impairment

> **NCT03399305** · — · WITHDRAWN · sponsor: **Albert Einstein College of Medicine**

## Conditions studied

- Renal Disease, End Stage
- Anticoagulant-induced Bleeding

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03399305
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-05-10
- **Primary completion:** 2019-07-07
- **Final completion:** 2022-08-24
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** investigators have decided not to continue with the study
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03399305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03399305, "Safety and Efficacy of Apixaban in Severe Renal Impairment". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03399305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*